Loading clinical trials...
Loading clinical trials...
ASSOCIATING LIVER PARTITION WITH PORTAL VEIN LIGATION FOR STAGED HEPATECTOMY (ALPPS) Versus Conventional Portal Vein Occlusion (PVO) for Resection of Liver Tumors Unresectable in One Step - a Randomized Controlled Trial
Conditions
Interventions
Associating liver partition and portal vein ligation for staged hepatectomy
Portal vein embolization or ligation
Locations
3
United States
Washington University
St Louis, Missouri, United States
Italian Hospital, Department of Surgery, Division of HPB surgery and Liver Transplatn Unit
Buenos Aires, Argentina
University Hospital Zurich, Division of Visceral and Transplant Surgery
Zurich, Canton of Zurich, Switzerland
Start Date
November 1, 2012
Primary Completion Date
November 1, 2015
Completion Date
November 1, 2015
Last Updated
June 9, 2015
Lead Sponsor
University of Zurich
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions